Table 5. New cases of disease that are averted or delayed in the first 10 years.
| Old recommendations | Eatwell Guide | Old recommendations without energy constraint | Eatwell Guide without energy constraint | ||
|---|---|---|---|---|---|
| Men | CHD | 59,000 (54,000 to 64,000) | 170,000 (160,000 to 180,000) | 40,000 (36,000 to 45,000) | 100,000 (93,000 to 110,000) |
| Stroke | 16,000 (15,000 to 18,000) | 80,000 (71,000 to 89,000) | 8,100 (5,800 to 10,000) | 14,000 (11,000 to 17,000) | |
| Diabetes | 280,000 (250,000 to 310,000) | 440,000 (400,000 to 480,000) | 44,000 (15,000 to 71,000) | 150,000 (110,000 to 200,000) | |
| Breast cancer | - | - | - | - | |
| Colorectal cancer | 64,000 (58,000 to 70,000) | 110,000 (99,000 to 110,000) | 39,000 (34,000 to 44,000) | 73,000 (65,000 to 82,000) | |
| Lung cancer | 13,000 (11,000 to 15,000) | 49,000 (42,000 to 55,000) | 14,000 (12,000 to 16,000) | 24,000 (20,000 to 28,000) | |
| Stomach cancer | 16,000 (15,000 to 18,000) | 28,000 (26,000 to 30,000) | 16,000 (14,000 to 17,000) | 27,000 (24,000 to 29,000) | |
| Pancreas cancer | -51 (-55 to -47)* | -140 (-150 to -130)* | -7,600 (-8,300 to -6,800) | -9,800 (-11,000 to -8,800) | |
| Kidney cancer | -58 (-62 to -54)* | -160 (-170 to -150)* | -850 (-950 to -750) | -1,100 (-1,200 to -990) | |
| Liver cancer | -59 (-64 to -55)* | -160 (-170 to -150)* | -2,500 (-2,800 to -2,200) | -3,300 (-3,600 to -2,900) | |
| Cirrhosis | -38 (-40 to -35)* | -100 (-110 to -95)* | -2,300 (-2,600 to -1,900) | -2,900 (-3,400 to -2,500) | |
| Women | CHD | 32,000 (29,000 to 34,000) | 94,000 (87,000 to 100,000) | 20,000 (17,000 to 23,000) | 54,000 (48,000 to 59,000) |
| Stroke | 17,000 (15,000 to 19,000) | 84,000 (74,000 to 94,000) | 8,600 (6,000 to 11,000) | 14,000 (11,000 to 18,000) | |
| Diabetes | 200,000 (180,000 to 220,000) | 340,000 (310,000 to 370,000) | -22,000 (-43,000 to 44) | 44,000 (9,700 to 80,000) | |
| Breast cancer | 19,000 (14,000 to 23,000) | 40,000 (31,000 to 49,000) | 12,000 (7,600 to 16,000) | 32,000 (23,000 to 41,000) | |
| Colorectal cancer | 33,000 (30,000 to 36,000) | 60,000 (55,000 to 65,000) | 24,000 (21,000 to 26,000) | 44,000 (39,000 to 49,000) | |
| Lung cancer | 8,700 (7,200 to 10,000) | 33,000 (28,000 to 37,000) | 9,200 (7,900 to 11,000) | 16,000 (13,000 to 19,000) | |
| Stomach cancer | 8,000 (7,200 to 8,900) | 15,000 (14,000 to 16,000) | 7,900 (7,000 to 8,700) | 14,000 (13,000 to 16,000) | |
| Pancreas cancer | -24 (-25 to -22)* | -71 (-75 to -66)* | -5,100 (-5,600 to -4,600) | -6,600 (-7,200 to -5,900) | |
| Kidney cancer | -3.8 (-4.0 to -3.5)* | -11.0 (-12.0 to -10.0)* | -210.0 (-240.0 to -190.0) | -280.0 (-310.0 to -250.0) | |
| Liver cancer | -19 (-20 to -18)* | -57 (-61 to -53)* | -2,000 (-2,200 to -1,900) | -2,600 (-2,800 to -2,400) | |
| Cirrhosis | -59 (-62 to -55)* | -170 (-180 to -160)* | -8,700 (-9,900 to -7,500) | -11,000 (-13,000 to -9,600) |
NB. CHD: coronary heart disease. Values are means and 95% uncertainty intervals.
* These numbers increase because people are living longer due to other diseases being prevented (i.e. there is no direct effect from a change in energy and BMI)